Synta Pharmaceuticals Corp. (SNTA) Jumps 12.06% on December 23

Equities Staff |

Synta Pharmaceuticals Corp. (SNTA) was among the biggest gainers on the Russell 2000 for Wednesday December 23 as the stock popped 12.06% to $0.36, representing a gain of $0.0386 per share. Some 1.91 million shares traded hands on 3,949 trades, compared with an average daily volume of 1.73 million shares out of a total float of 137.79 million. The stock opened at $0.31 and traded with an intraday range of $0.36 to $0.31.

After today's gains, Synta Pharmaceuticals Corp. reached a market cap of $49.44 million. Synta Pharmaceuticals Corp. has had a trading range between $3.17 and $0.29 over the last year, and it had a 50-day SMA of $0.66 and a 200-day SMA of $1.83.

Synta Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in research, development and commercialization of novel oncology medicines that have the potential to change the lives of cancer patients.

Synta Pharmaceuticals Corp. is based out of Lexington, MA and has some 110 employees. Its CEO is Chen Schor.

For a complete fundamental analysis analysis of Synta Pharmaceuticals Corp., check out Equities.com’s Stock Valuation Analysis report for SNTA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

IBC Advanced Alloys Corp.

IBC Advanced Alloys Corp is engaged in the production and development of specialty alloy products. Its products include copper alloys and berryllium aluminium alloys.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

Snapchat

Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…